123 related articles for article (PubMed ID: 2559750)
1. A novel method for the purification of HIV-1 p24 protein from hybrid Ty virus-like particles (Ty-VLPs).
Gilmour JE; Senior JM; Burns NR; Esnouf MP; Gull K; Kingsman SM; Kingsman AJ; Adams SE
AIDS; 1989 Nov; 3(11):717-23. PubMed ID: 2559750
[TBL] [Abstract][Full Text] [Related]
2. Performance characteristics of a novel immunoassay based on hybrid Ty virus-like particles (Ty-VLPs): rapid differentiation between HIV-1 and HIV-2 infection.
Gilmour JE; Read SJ; Eglin R; Ryan C; Burns NR; Graff N; Stenner N; Kingsman SM; Kingsman AJ; Adams SE
AIDS; 1990 Oct; 4(10):967-73. PubMed ID: 2124493
[TBL] [Abstract][Full Text] [Related]
3. Immunization of human HIV-seronegative volunteers with recombinant p17/p24:Ty virus-like particles elicits HIV-1 p24-specific cellular and humoral immune responses.
Martin SJ; Vyakarnam A; Cheingsong-Popov R; Callow D; Jones KL; Senior JM; Adams SE; Kingsman AJ; Matear P; Gotch FM
AIDS; 1993 Oct; 7(10):1315-23. PubMed ID: 8267904
[TBL] [Abstract][Full Text] [Related]
4. Immunogenicity of the yeast recombinant p17/p24:Ty virus-like particles (p24-VLP) in healthy volunteers.
Weber J; Cheinsong-Popov R; Callow D; Adams S; Patou G; Hodgkin K; Martin S; Gotch F; Kingsman A
Vaccine; 1995 Jun; 13(9):831-4. PubMed ID: 7483805
[TBL] [Abstract][Full Text] [Related]
5. HIV p24-specific helper T cell clones from immunized primates recognize highly conserved regions of HIV-1.
Mills KH; Kitchin PA; Mahon BP; Barnard AL; Adams SE; Kingsman SM; Kingsman AJ
J Immunol; 1990 Mar; 144(5):1677-83. PubMed ID: 1689753
[TBL] [Abstract][Full Text] [Related]
6. An ELISA-inhibition assay for antibody to human immunodeficiency virus core antigen (p24).
Povolotsky J; Gold JW; Darminin P; Chein N; Baron P; Armstrong D
J Virol Methods; 1990 Oct; 30(1):109-14. PubMed ID: 2128300
[TBL] [Abstract][Full Text] [Related]
7. A peptide library expressed in yeast reveals new major epitopes from human immunodeficiency virus type 1.
Madaule P; Gairin JE; Bénichou S; Rossier J
FEMS Microbiol Immunol; 1991 Apr; 3(2):99-107. PubMed ID: 1713777
[TBL] [Abstract][Full Text] [Related]
8. Differences in human immunodeficiency virus type 1 (HIV-1) anti-p24 reactivities in serum of HIV-1-infected and uninfected subjects: analysis of indeterminate western blot reactions.
Povolotsky J; Gold JW; Chein N; Baron P; Armstrong D
J Infect Dis; 1991 Feb; 163(2):247-51. PubMed ID: 1899100
[TBL] [Abstract][Full Text] [Related]
9. Expression and purification of p24, the core protein of HIV, using a baculovirus-insect cell expression system.
Mills HR; Jones IM
AIDS; 1990 Nov; 4(11):1125-31. PubMed ID: 2126440
[TBL] [Abstract][Full Text] [Related]
10. Cleavage of procaryotically expressed human immunodeficiency virus fusion proteins by factor Xa and application in western blot (immunoblot) assays.
Ellinger S; Glockshuber R; Jahn G; Plückthun A
J Clin Microbiol; 1989 May; 27(5):971-6. PubMed ID: 2501357
[TBL] [Abstract][Full Text] [Related]
11. The production of hybrid Ty:IFN virus-like particles in yeast.
Malim MH; Adams SE; Gull K; Kingsman AJ; Kingsman SM
Nucleic Acids Res; 1987 Sep; 15(18):7571-80. PubMed ID: 2821510
[TBL] [Abstract][Full Text] [Related]
12. Epitope mapping of the HIV-1 gag region by analysis of gag gene deletion fragments expressed in Escherichia coli defines eight antigenic determinants.
Marcus-Sekura CJ; Woerner AM; Zhang PF; Klutch M
AIDS Res Hum Retroviruses; 1990 Mar; 6(3):317-27. PubMed ID: 1692722
[TBL] [Abstract][Full Text] [Related]
13. The expression of hybrid HIV:Ty virus-like particles in yeast.
Adams SE; Dawson KM; Gull K; Kingsman SM; Kingsman AJ
Nature; 1987 Sep 3-9; 329(6134):68-70. PubMed ID: 3041226
[TBL] [Abstract][Full Text] [Related]
14. Cleavage and purification of prokaryotically expressed HIV gag and env fusion proteins for detection of HIV antibodies in the ELISA.
Ellinger S; Mach M; Korn K; Jahn G
Virology; 1991 Feb; 180(2):811-3. PubMed ID: 1989391
[TBL] [Abstract][Full Text] [Related]
15. Immune response to a major epitope of p24 during infection with human immunodeficiency virus type 1 and implications for diagnosis and prognosis.
Janvier B; Baillou A; Archinard P; Mounier M; Mandrand B; Goudeau A; Barin F
J Clin Microbiol; 1991 Mar; 29(3):488-92. PubMed ID: 1709947
[TBL] [Abstract][Full Text] [Related]
16. Epitope location of 13 anti-gag HIV-1 monoclonal antibodies using oligopeptides and their cross reactivity with HIV-2.
Ferns RB; Partridge JC; Spence RP; Hunt N; Tedder RS
AIDS; 1989 Dec; 3(12):829-34. PubMed ID: 2483619
[TBL] [Abstract][Full Text] [Related]
17. The cloning and expression in Escherichia coli of sequences coding for p24, the core protein of human immunodeficiency virus, and the use of the recombinant protein in characterizing a panel of monoclonal antibodies against the viral p24 protein.
Spence RP; Jarvill WM; Ferns RB; Tedder RS; Parker D
J Gen Virol; 1989 Nov; 70 ( Pt 11)():2843-51. PubMed ID: 2479710
[TBL] [Abstract][Full Text] [Related]
18. Identification of a potent synthetic HIV1 immunogen compromising gag-P24 tandem T- and B-cell epitopes.
Chong P; Sia C; Sydor M; Klein M
FEBS Lett; 1990 May; 264(2):231-4. PubMed ID: 1694143
[TBL] [Abstract][Full Text] [Related]
19. Identification of regions of HIV-1 p24 reactive with sera which give "indeterminate" results in electrophoretic immunoblots with the help of long synthetic peptides.
Blomberg J; Vincic E; Jönsson C; Medstrand P; Pipkorn R
AIDS Res Hum Retroviruses; 1990 Dec; 6(12):1363-72. PubMed ID: 2127683
[TBL] [Abstract][Full Text] [Related]
20. A conserved idiotype and antibodies to retroviral proteins in systemic lupus erythematosus.
Talal N; Garry RF; Schur PH; Alexander S; Dauphinée MJ; Livas IH; Ballester A; Takei M; Dang H
J Clin Invest; 1990 Jun; 85(6):1866-71. PubMed ID: 2112156
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
